Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: A multicentre randomised controlled trial

Gut

Volumn 58, Issue 8, 2009, Pages 1144-1150

  Garcia Pagan J C ^a,b   Villanueva, C ^b,c   Albillos, A ^b,d   Banares R ^b,e   Morillas, R ^b,f   Abraldes, J G ^a,b   Bosch, J ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL SANT PAU   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE MONONITRATE; NADOLOL;

ADULT; ANGIOSCOPY; ARTICLE; ASTHENIA; BLEEDING; BRADYCARDIA; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; DIZZINESS; DRUG SAFETY; FEMALE; FOLLOW UP; GLAUCOMA; HEADACHE; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; HYPOTENSION; IMPOTENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VENOUS PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; ISOSORBIDE DINITRATE; LIGATION; MALE; MIDDLE AGED; NADOLOL; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 67650251634     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.171207     Document Type: Article

References (25)

1. Bosch J, Garcia-Pagan J. Prevention of variceal rebleeding. Lancet 2003;361:952-4.
2. Villanueva C, Minana J, Ortiz J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647-55.
3. Patch D, Sabin CA, Goulis J, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002;123:1013-9.
4. Lo GH, Chen WC, Chen MH, et al. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002;123:728-34.
5. Romero G, Kravetz D, Argonz J, et al. Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Aliment Pharmacol Ther 2006;24:601- 11.
6. de Franchis R. Evolving Consensus in Portal Hypertension: Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-76.
7. Lo GH, Lai KH, Cheng JS, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 2000;32:461-5.
8. de la PJ, Brullet E, Sanchez-Hernandez E, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 2005;41:572-8.
9. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 2007;102:2086-102.
10. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46:922-38.
11. Jha SK, Kumar A, Sharma BC, et al. Endoscopic variceal ligation (EVL) plus propranolol (P) and isosorbide mononitrate (ISMN) versus EVL alone in secondary prophylaxis of variceal bleeding: a prospective RCT. Hepatology 2007;46(suppl 1):250A.
12. D'Amico G, Garcia-Pagan JC, Luca A, et al. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006;131:1611-24.
13. Feu F, Garcia-Pagan JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1056-9.
14. Abraldes JG, Tarantino I, Turnes J, et al. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003;37:902-8.
15. Garcia-Pagan JC, Navasa M, Bosch J, et al. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis. Hepatology 1990;11:230-8.
16. Morillas RM, Planas R, Cabre E, et al. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects. Hepatology 1994;20:1502-8.
17. Villanueva C, Balanzo J, Novella MT, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 1996;334:1624-9.
18. Bosch J, Garcia-Pagan JC, Berzigotti A, et al. Measurement of portal pressure and its role in the management of chronic liver disease. Semin Liver Dis 2006;26:348-62.
19. Dunnett CW, Gent M. An alternative to the use of two-sided tests in clinical trials. Stat Med 1996;15:1729-38.
20. Sackett DL. The principles behind the tactics of performing therapeutic trials. In: Haynes B, Sackett DL, Guyatt G, Tulliez M, eds. Clinical epidemiology. Lippincott Williams & Wilkins, 2006: 173-243.
21. Bosch J, Abraldes JG, Berzigotti A, et al. Portal hypertension and gastrointestinal bleeding. Semin Liver Dis 2008;28:3-25.
22. Gonzalez R, Zamora J, Gomez-Camarero J, et al. Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med 2008;149:109-22.
23. Avgerinos A, Armonis A, Stefanidis G, et al. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology 2004;39:1623-30.
24. Villanueva C, Piqueras M, Aracil C, et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol 2006;45:560-7.
25. Bureau C, Peron JM, Alric L, et al. "A la carte" treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 2002;36:1361- 6.